Login to My NLA Account

News Stories

Dec, 2020

National Lipid Association Announces Late-Breaking Abstract Presentations at NLA 2020 Virtual Scientific Sessions

 
JACKSONVILLE, Fla. – (December 10, 2020) – The National Lipid Association announced today that it will feature three key late breaking scientific abstract presentations at its 2020 Virtual Scientific Sessions starting today. The late-breaker abstracts include:
 

    0
    No votes yet
    Name: NLA News
    Aug, 2020

    Regeneron Pharmaceuticals, Inc. today announced that the New England Journal of Medicine (NEJM) published positive results from the Phase 3 trial of evinacumab in 65 patients with homozygous familial hypercholesterolemia (HoFH).

    0
    No votes yet
    Name: NLA News
    Aug, 2020

    The NLA is excited to share that we will host our first-ever virtual Scientific Sessions! Due to current travel restrictions and gathering limitations in the city of Chicago, the NLA has made the difficult decision to rescope our 2020 Scientific Sessions into a fully virtual conference held live on Thursday, December 10 – Saturday, December 12, 2020.

    There will be a reduced meeting registration for the virtual conference at a discounted rate of only $299.  Registration for the virtual sessions will open at the end of August.

    0
    No votes yet
    Name: NLA News